Risk Factors for the Progression of Mild Cognitive Impairment in Different Types of Neurodegenerative Disorders

Area of Science:

• Neurology
• Geriatrics
• Cognitive Science

Background:

• Mild cognitive impairment (MCI) represents a critical transitional phase between normal cognitive aging and dementia.
• The etiology and clinical progression of MCI are highly heterogeneous, complicating diagnosis and management.
• Understanding factors influencing MCI progression is crucial for early intervention and dementia prevention strategies.

Purpose of the Study:

• To investigate the specific factors associated with the progression of mild cognitive impairment (MCI) across different dementia subtypes.
• To identify risk and protective factors influencing the conversion of MCI to Alzheimer's disease, vascular cognitive impairment, and Lewy body diseases.
• To analyze the relationship between patient characteristics, comorbidities, and medication use with MCI progression.

Main Methods:

• A retrospective, longitudinal, observational study design was employed.
• Data were collected from outpatients diagnosed with MCI at a medical center in northern Taiwan.
• Multivariate analysis was used to examine risk factors associated with MCI progression.

Main Results:

• Out of 279 MCI patients, 37.2% progressed to dementia during the observation period.
• Older age and higher Clinical Dementia Rating Scale-Sum of Boxes scores were significant risk factors for progression.
• Hyperlipidemia was associated with a reduced risk of progression, while antidementia prescriptions were more common in converters.

Conclusions:

• Comprehensive clinical profiling, including detailed drug history and risk factor assessment, is vital for understanding and managing diverse dementia subtypes.
• Identifying specific predictors of MCI progression can aid in early diagnosis and tailored therapeutic strategies.
• Further research into the protective role of conditions like hyperlipidemia may reveal novel avenues for dementia prevention.